Navigation Links
SuperGen Reports 2007 Fourth Quarter and Annual Financial Results

Company Achieves 2007 Net Income of $13.1 Million

DUBLIN, Calif., March 3 /PRNewswire-FirstCall/ -- SuperGen Inc., (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today reported financial results for the fourth quarter and year ended December 31, 2007.

The Company reported net income for the 2007 fourth quarter of $5.1 million, or $0.09 per fully diluted share, compared with a net loss of $6.3 million, or $0.11 per fully diluted share, for the same prior year period. The Company reported net income for the year ended December 31, 2007 of $13.1 million, or $0.23 per fully diluted share, compared with a net loss of $16.5 million, or $0.31 per fully diluted share, for the same prior year period.

Highlights for 2007 include:

-- Dacogen royalty revenue was $22.3 million compared to $3.4 million for


-- A major contributor to net income during 2007 was the gain on

disposition of non-core assets including the sale of worldwide rights

for Nipent(R) (pentostatin for injection) and Surface Safe(R),

resulting in a reported gain on sale of products of $33.7 million.

-- The Company closed the year with unrestricted cash, cash equivalents,

and marketable securities totaling approximately $91 million.

"SuperGen has again achieved several significant milestones during 2007 including the start of Phase 1 and Phase 1b clinical trials of MP470, a novel, oral, multi-targeted tyrosine kinase inhibitor (TKI)," said Dr. James Manuso, President and Chief Executive Officer. "We entered 2008 with a strong financial position. Our lice

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
2. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
3. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
4. Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
5. Genetic Engineering & Biotechnology News reports on advances in miRNA
6. Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
7. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
8. Cepheid Reports Fourth Quarter and Full Year 2007 Results
9. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
10. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
11. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
Post Your Comments:
(Date:10/8/2015)... ... October 08, 2015 , ... Cystic fibrosis ... conductance regulator (CFTR) gene and results in dysfunction of the lungs and the ... the lungs. This mucus is very difficult to clear, blocks the airways and ...
(Date:10/7/2015)... Texas (PRWEB) , ... October 07, 2015 , ... ... Institute ( ) will present a public educational seminar on the latest ... Saturday, October 10th from 1:00 pm – 3:00 pm at the Hilton Dallas/Southlake ...
(Date:10/7/2015)... TRIANGLE PARK, N.C. , Oct. 7, 2015  October ... the campaign, TRL has committed to donating a portion ... current liver research and hepatology practices. ... furthering liver research in a variety of ways; whether ... scientists around the world, collaborating with researchers in different ...
(Date:10/7/2015)... ... October 07, 2015 , ... ... has appointed S. Russel Craig of Spectral Platforms, and Michael Ward of Wrenward ... line management and consulting experience. Currently he is Executive Vice President of Strategic ...
Breaking Biology Technology:
... YORK, July 14, 2011 Coloredge New York - Los ... Graphics Approved Printer Network. A one year alliance, ... Coloredge New York - Los Angeles, was one of 17 ... testing, training and sustainability leadership. Coloredge New York ...
...   Executives from O2h (Cambridge, UK) and ... the number of FTE chemists provided by O2h to support,discovery ... Chemistry at Heptares said, "O2h has,been a valuable partner for ... team to include a full lab unit at,O2h." ...
... soil to release the potent greenhouse gases methane and nitrous ... Nature reveals. "This feedback to our changing atmosphere means ... as we previously thought," said Dr Kees Jan van Groenigen, ... Natural Sciences, Trinity College Dublin, and lead author of the ...
Cached Biology Technology:
(Date:9/29/2015)... -- iDAvatars is excited to be named one of the first ... official announcement was recently made at an invite-only IBM ... San Francisco , where iDAvatars presented a demo of ... "It is both an honor and a privilege to ... market the cognitive power of IBM Watson in our product, ...
(Date:9/28/2015)... , September 28, 2015 The ... to reach USD 12.03 billion by 2020, growing at ... advancements such as Backside Illumination (BSI) technique to improve ... the forecast period.      (Logo: , ... the chip to reduce loss and, thus, reduce the ...
(Date:9/26/2015)... , Sept. 26th, 2015  Results of ... will be unveiled today at the Stanford Medicine ... Engagement Using iPad Dashboards, Connected Health Devices and ... of Pharmacy 3.0, will explain how senior patients ... data to their pharmacist via the TactioRPM remote ...
Breaking Biology News(10 mins):
... Northwest (PNW) Research Station has published a report about ... in a changing climate. The report is available online ... print beginning July 9. Titled Water, Climate ... the publication describes healthy, resilient watersheds as a primary ...
... 29 June 2010, announces this year,s award winners with ... theoretical physicist Professor Edward Witten for outstanding, transformative contributions ... physicists of the past 30 years, he has had ... physics and cosmology to theoretical areas of string theory ...
... who drink alcohol while they are pregnant may be damaging ... to be presented at the 26th annual meeting of the ... (Tuesday 29 June). Doctors in Denmark found that if ... pregnant, then the sperm concentration of their sons, measured about ...
Cached Biology News:
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
... to Cholesterol Oxidase Immunogen Cholesterol ... Cross-reacts with bacteria. Not yet tested in ... oxidases exist as both type I and ... bacterial pathogenesis. In addition, they are important ...
Rabbit polyclonal to SERHL ( Abpromise for all tested applications). entrezGeneID: 94009 SwissProtID: Q9H4I8...
... anti-phospho-PTEN (Ser385) ... amino acid region encompassing the ... (Ser385), Accession ... Quality Assurance: Routinely ...
Biology Products: